LOGO 2120
Pill imprint LOGO 2120 has been identified as Valproic acid 250 mg.
Valproic acid is used in the treatment of seizures; seizure prevention; schizoaffective disorder; mania; migraine prevention (and more), and belongs to the drug class fatty acid derivative anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Valproic acid 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Valproic acid Images
- Imprint:
-
LOGO 2120
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- United Research Laboratories/Mutual Pharmaceutical Company
Advertisement
More Valproic Acid resources
- Valproate (Wolters Kluwer)
- Valproate Syrup (Wolters Kluwer)
- Valproic Acid (Wolters Kluwer)
- Valproic Acid Delayed-Release Capsules (Wolters Kluwer)
- Valproic Acid Syrup (Wolters Kluwer)
- valproic acid (Cerner Multum)
- Alti-Valproic (Micromedex) - Includes Dosage Information
- Depakote (Micromedex) - Includes Dosage Information
- Depakote DR (Micromedex) - Includes Dosage Information
- Depakote ER (Micromedex) - Includes Dosage Information
- Depakote Sprinkles (Micromedex) - Includes Dosage Information
- Epiject Iv (Micromedex) - Includes Dosage Information
- valproate sodium Intravenous (Micromedex) - Includes Dosage Information
- valproic acid (Micromedex) - Includes Dosage Information
- Valproate (FDA)
- Valproic Acid Capsules (FDA)
- Valproic Acid Oral Solution (FDA)
- Valproic Acid Syrup (FDA)
Search Again
